Pathology of multiple sclerosis: progression of the lesion.
نویسنده
چکیده
Adams C W M, Ibrahim M Z M & Leibowitz S (1965) In: Adams C W M, ed. Neurohistochemistry, pp. 437-487. Hsevier, Amsterdam & London Adams C W M, Bayliss O B & Turner D R (1975) / . Patkol. 116,225-238 Adams R D & Kubik C S (1952) Am. J. Med. 12, 510-546 Adams R D & Richardson E P Jr (1961) In: Folch-Pi J, ed. Chemical pathology of the nervous system, pp. 162-196 (Proceedings of the Third International Neurochemical Symposium, Strasbourg, 1958). Pergamon Press, Oxford Adams R D & Sidman R L (1968) Introduction to neuropatkohgy, pp. 149-170. McGraw-Hill, New York Bignami A & Eng L F (1973) / . Neurochem. 20,165-173 Bignami A & Ralston H J f f l (1969) Brain Res. 13,444-461 Birley J L & Dudgeon L S (1921) Brain. 44,150-212 Bowen D M & Davison A N (1974) / . Neurol. Sd. 21, 227-231 Broman T (1964) Ada Neurol. Scand suppl. no. 10, pp. 21-24 Cumings J N (1953) Brain, 76, 551-562 Cumings J N (1955) Brain, 78, 554-563 Dawson J W (1916) Edinburgh Med. J. n.s. 17, 311-344,377-410 Day A J (1964) / . Atheroscler. Res. 4,117-130 Einstein E R, Csejtey J & Marks N (1968) FEBSLett. 1,191-195 Einstein E R, Dalai K B & Csejtey J (1970) / . Neurol Sd. 11, 109-121 Einstein E R, Csejtey J, Dalai KB, Adams CWM, Bayliss OB & HaUpike J F (1972) / . Neurochem. 19, 653-662 Fcigin I & Ogata J (1971)/. Neuropathol. Exp. Neurol. 30,603-612 Feigin I & Popoff N (1966) Neurology, 16, 364-372 Fog T (1964) Ada Neurol. Scand. suppl. no. 10, pp. 9-15 Friede R L (1961) Arch. Neurol. (Chicago) 5,433-443 Friede R L & Knolkr M (1964) Experlentia, 20,130-132 Gallai-Hatchard J, Magee W L, Thompson R H S & Webster G R (1962) / . Neurochem. 9, 545-554 Gregson N A & Hall S M (1973) / . Cell Sd. 13, 257-277 Hallpike J F & Adams C W M (1969) Histochem. J. 1, 559-578 Hallpike J F, Adams C W M & Bayliss O B (1970a) Histochenu J. 2, 315-321 Hallpike J F, Adams C W M & Bayliss O B (1970b) Histochem. J. 2.199-208 Hallpike J F, Adams C W M & Bayliss O B (1970c) Histochem. J. 2, 323-328 Hirsch H E, Duquette P & Parks M E (1976) J. Neurochem. 26,505-512 Ibrahim M Z M & Adams C W M (1963) / . Neurol. Neurosurg. Psychlat. 26,101-110 Ibrahim M Z M & Adams C W M (1965) / . Pathol. Bacterial. 90,239-243 Johnson A C, McNabb A R & Rossiter R J (1950) Arch. Neurol. Psychiatry (Chicago) 64,105-121 Lampert P W (1969) Lab. Invest. 20,127-138 Lampert P W & Cressman M R (1966) Am. J. Pathol. 49,1139-1155 Lampert P W & Kies M W (1967) Exp. Neurol. 18,210-223 Lumsden C E (1951) Br. Med. J. 1,1035-1043 Lumsden C E (1970) In: Vinken P J & Bruyn G W, ed. Handbook of clinical neurology. Vol. 9: Multiple sclerosis and other demyeUnating diseases, pp. 217-309. North-Holland, Amsterdam Lumsden C E (1972) In: McAlpine D, Lumsden C E & Acheson E D. Multiple sclerosis: a reappraisal, 2nd ed., pp. 314-321. Churchill Livingstone, Edinburgh McCaman R E & Robins E (1959)7. Neurochem. 5,18-31 McDonald W I (1974) Br. Med. Bull. 30,186-189 Marples E A, Thompson R H S & Webster G R (1959) / . Neurochem. 4,62-70 Petrescu A (1966) Ann. Histochim. 11,237-252 Petrescu A (1969) Wiener Z. Nervenheilkd. suppl. no. 2, pp. 38-52 Prineas J (1975) Hum. Pathol. 6, 531-554 Prineas J & Raine C S (1976) Neurology, 26, no. 6, pt 2, pp. 29-32 Riekklnen P J, Clausen J, Frey H J, Fog T & Rinne U K (1970) Ada Neurol. Scand. 46, 349-353 Riekkinen P J, Palo J, Arstila A U, Savolainen H J, Rinne U K, Kivalo E K & Frey H (1971a) Arch. Neurol. (Chicago) 24, 545-549 Riekkinen P [Jl Rinne U K, Savolainen H [JJ.Palo J,KivaloE[K] & Arstila A [U] (1971b) Eur. Neurol. 5, 229-244 Seitelberger F (1960) In: Cumings J N, ed. Modem scientific aspects of neurology, pp. 146-187. Arnold, London Siemerling E & Raecke J (1914) Arch. Psychiatr. Nervenkr. 53,385-564 Suzuki K, Andrews J M, Waltz J M & Terry R D (1969) Lab. Incest. 20,444-454 Symonds C P (1924) Brain, 47, 36-56 Tanaka R, Iwasaki Y & Koprowski H (1975) Am. J. Pathol. 81,467-478 Thompson R H S (1961) Proc. R. Soc. Med. 54, 30-33 Tourtellotte W W (1970) In: Vinken PJ&BruynGW.ed.Handbook of clinical neurology. Vol. 9: Multiple sclerosis and other demyeltnating diseases, pp. 324-382. North-Holland, Amsterdam Tuqan N A & Adams C W M (1961) / . Neurochem. 6, 327-333 Waksman B H & Adams R D (1962) / . Neuropathol. Exp. Neurol. 21, 491-518 Webster G R (1957) Nature (London) 180, 660-661 [Letter] Webster G R & Thompson R H S (1962) Biochim. Biophys. Ada, 63, 38-^5 Wisniewski H M & Bloom B R (1975) / . Exp. Med. 141, 346-359
منابع مشابه
Association of CD24V/V Genotype with Susceptibility and Progression of Multiple Sclerosis in Iranian Population
A single nucleotide polymorphism (SNP) in CD24 has been associated with multiple sclerosis (MS) in a population based study. This SNP results in the replacement of alanine (CD24A) by valine (CD24V) at amino acid 57 in the resulting polypeptide chain. In the current study, the genotyping of this SNP and its contribution to MS in 217 patients and 200 healthy individuals of an Iranian population w...
متن کاملOral and Laryngeal Diadochokinetic Rate in Multiple Sclerosis: Relationship to Disease Progression
Background: The first purpose of this study was to investigate the rate of oral and laryngeal Diadochokinesis (DDK) in Multiple Sclerosis (MS) patients in comparison with healthy people. The second goal was to determine if DDK rate has any relationship with the disease progression. Methods: In this cross-sectional study, two groups were enroll...
متن کاملCross-talks between the kidneys and the central nervous system in multiple sclerosis
Multiple sclerosis (MS) is an inflammatory demyelinating disease, which is considered as a common autoimmune disorder in young adults. A growing number of evidences indicated that the impairment in non-neural tissues plays a significant role in pathology of MS disease. There are bidirectional relationship, metabolic activities and functional similarity between central nervous system (CNS) and k...
متن کاملRepeated Administration of Mercury Accelerates Progression of Multiple Sclerosis through Mitochondrial Dysfunction
Multiple Sclerosis (MS) is a neurodegenerative and autoimmune disease that it’s molecular etiology and factors involving in its progression remains unknown. In this study for evaluation effect of mercuric on progression of MS we investigated the additive effect of mercuric sulfide on the brain mitochondrial dysfunction in experimental autoimmune encephalomyelitis (EAE) model of MS in C57BL/6 mi...
متن کاملRepeated Administration of Mercury Accelerates Progression of Multiple Sclerosis through Mitochondrial Dysfunction
Multiple Sclerosis (MS) is a neurodegenerative and autoimmune disease that it’s molecular etiology and factors involving in its progression remains unknown. In this study for evaluation effect of mercuric on progression of MS we investigated the additive effect of mercuric sulfide on the brain mitochondrial dysfunction in experimental autoimmune encephalomyelitis (EAE) model of MS in C57BL/6 mi...
متن کاملارزش پیشگوییکنندۀ CSF IgG در اسکلروز متعدد: مطالعه در 54 بیمار
Background: Multiple sclerosis (MS) is an inflammatory disease of the central nervous system with multifocal areas of demyelination. Despite an increased understanding of the mechanisms causing MS, immunological factors that indicate disease activity are only starting to be discovered. Chronic brain inflammation is often associated with an increase in production of IgG in the CSF as determined ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- British medical bulletin
دوره 33 1 شماره
صفحات -
تاریخ انتشار 1977